NASDAQ · Dividend

Denali Therapeutics Inc. (DNLI) Dividend

$18.41 NASDAQ: DNLI Market Cap $2.94B

Metric	Value
Dividend Yield	None
Indicated Annual Dividend	—
Payout Ratio	—
FCF Yield	-13.78%
Current Price	$18.41

Dividend Analysis

Denali Therapeutics Inc. (DNLI) does not currently pay a dividend, based on the latest available data. Companies that do not pay dividends may use earnings for reinvestment, acquisitions, share buybacks, or debt repayment instead.

Free cash flow yield of -13.78% is below the 0.00% dividend yield, so the dividend is not fully covered by free cash flow at the current price.

Dividend yield against peers

Denali Therapeutics Inc. has the lowest dividend yield of the 6 companies compared here.

Company	Yield	P/E	Price
Alector, Inc. (ALEC)	0.00%	-1.74	$1.83
Amylyx Pharmaceuticals, Inc. (AMLX)	0.00%	-19.71	$27.20
Biohaven Ltd. (BHVN)	0.00%	-2.77	$13.88
Cognition Therapeutics, Inc. (CGTX)	0.00%	-4.82	$0.72
Ionis Pharmaceuticals, Inc. (IONS)	0.00%	-12.57	$42.93
Denali Therapeutics Inc. (DNLI)	0.00%	-7.04	$18.41